Latest Period
Q2 2026
Security Snapshot
IMMUNIC, INC. - Common Stock, par value $0.0001 (IMUX) Institutional Ownership
CUSIP: 4525EP200
13F Institutional Holders and Ownership History from Q1 2026 to Q2 2026
Institutions Reporting
55
Shares (Excl. Options)
8,438,939
Price
$15.37
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001
- Symbol
- IMUX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 8,438,939
- Total 13F value
- $129,707,199
- Portfolio coverage rank
- 0%
- Share change
- +7,463,059
- Value change
- +$114,707,952
- Number of holders
- 55
- Shares outstanding
- 15,270,919
- SEC-reported price per share
- $16.58
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- IMUX - IMMUNIC, INC. - Common Stock, par value $0.0001 is tracked under CUSIP 4525EP200.
- 55 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 3 to 55 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,057,797 to $129,707,199.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 55 institutions filings for Q2 2026.
Security key
4525EP200
Latest holder period
Q2 2026
13F holders
55
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
IMUX full holder history
IMMUNIC, INC. SEC filings
IMMUNIC, INC. company facts
IMMUNIC, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 4525EP200:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
IMUX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Commodore Capital LP | 9.9% | $22,133,059 | 1,511,821 | Commodore Capital LP | 30 Jun 2026 | |||
| Nantahala Capital Management, LLC | 7.5% | $15,808,902 | 1,079,843 | Nantahala Capital Management, LLC | 30 Jun 2026 | |||
| INTEGRATED CORE STRATEGIES (US) LLC | 7% | $14,194,168 | 969,547 | Millennium Management LLC | 30 Jun 2026 | |||
| Laurion Capital Management LP | 6.1% | $12,290,661 | 839,526 | Laurion Capital Management LP | 30 Jun 2026 | |||
| Aberdeen Group plc | 6% | $12,703,896 | 824,393 | Aberdeen Group plc | 30 Jun 2026 | |||
| Soleus Capital Master Fund, L.P. | 4.9% | $9,943,488 | 679,200 | Soleus Capital Master Fund, L.P. | 30 Jun 2026 |
As of 30 Jun 2026, 55 institutional investors reported holding 8,438,939 shares of IMMUNIC, INC. - Common Stock, par value $0.0001 (IMUX). This represents 55% of the company’s total 15,270,919 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
54%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Aberdeen Group plc | 5.4% | 824,393 | 0.02% | $12,670,920 | |
| BVF INC/IL | 5% | 765,295 | 0.3% | $11,762,584 | |
| MILLENNIUM MANAGEMENT LLC | 4.8% | 740,347 | 0.01% | $11,379,133 | |
| Avidity Partners Management LP | 4.4% | 669,941 | 1.6% | $10,296,993 | |
| BRAIDWELL LP | 4.2% | 645,010 | 0.37% | $9,913,804 | |
| Laurion Capital Management LP | 4% | 610,326 | 0.68% | $9,380,711 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7% | 571,561 | 0% | $8,784,893 | |
| Jones Hill Capital LP | 3.5% | 539,814 | 1.8% | $8,296,941 | |
| Woodline Partners LP | 3.1% | 471,528 | 0.02% | $7,247,385 | |
| Soleus Capital Management, L.P. | 2.9% | 450,000 | 0.24% | $6,916,500 | |
| Propel Bio Management, LLC | 2.1% | 325,022 | 2.6% | $4,995,588 | |
| Nantahala Capital Management, LLC | 1.6% | 250,646 | 0.23% | $3,852,429 | |
| UBS Group AG | 1.2% | 175,756 | 0% | $2,701,369 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 170,675 | 0% | $2,624,347 | |
| 683 Capital Management, LLC | 0.96% | 147,245 | 0.21% | $2,263,156 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.92% | 139,860 | 0% | $2,149,648 | |
| BlackRock, Inc. | 0.87% | 132,791 | 0% | $2,040,998 | |
| MARSHALL WACE, LLP | 0.69% | 104,816 | -89% | 0% | $1,611,022 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.6% | 90,890 | 0% | $1,396,979 | |
| JANE STREET GROUP, LLC | 0.59% | 89,687 | 0% | $1,378,489 | |
| Jefferies Financial Group Inc. | 0.56% | 84,900 | 0.01% | $1,304,913 | |
| VANGUARD FIDUCIARY TRUST CO | 0.54% | 82,029 | 0% | $1,260,786 | |
| Ikarian Capital, LLC | 0.44% | 67,464 | 0.17% | $1,036,922 | |
| Quadrature Capital Ltd | 0.25% | 37,786 | 0% | $580,771 | |
| Simplify Asset Management Inc. | 0.2% | 30,725 | 0.01% | $472,243 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
Q2 2026
Rows shown
1-2 of 2